These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35834041)

  • 1. Antitumor activity of mianserin (a tetracyclic antidepressant) primarily driven by the inhibition of SLC1A5-mediated glutamine transport.
    Duan Z; Zhou Z; Lu F; Zhang Y; Guo X; Gui C; Zhang H
    Invest New Drugs; 2022 Oct; 40(5):977-989. PubMed ID: 35834041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
    Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
    Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA
    Jiang J; Dong W; Zhang W; Wang Q; Wang R; Wang J; Wu H; Dong H; Zhao RC; Wang J; Li Z
    Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.
    Lin J; Yang T; Peng Z; Xiao H; Jiang N; Zhang L; Ca D; Wu P; Pan Q
    Cell Physiol Biochem; 2018; 48(1):397. PubMed ID: 30071532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.
    Kawakami I; Yoshino H; Fukumoto W; Tamai M; Okamura S; Osako Y; Sakaguchi T; Inoguchi S; Matsushita R; Yamada Y; Tatarano S; Nakagawa M; Enokida H
    Biochem Biophys Res Commun; 2022 Jun; 611():99-106. PubMed ID: 35487063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEAD1 (TEA Domain Transcription Factor 1) Promotes Smooth Muscle Cell Proliferation Through Upregulating SLC1A5 (Solute Carrier Family 1 Member 5)-Mediated Glutamine Uptake.
    Osman I; He X; Liu J; Dong K; Wen T; Zhang F; Yu L; Hu G; Xin H; Zhang W; Zhou J
    Circ Res; 2019 Apr; 124(9):1309-1322. PubMed ID: 30801233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Pulmonary Fibrosis by SLC1A5-Dependent Glutamine Transport Blockade.
    Choudhury M; Schaefbauer KJ; Kottom TJ; Yi ES; Tschumperlin DJ; Limper AH
    Am J Respir Cell Mol Biol; 2023 Oct; 69(4):441-455. PubMed ID: 37459644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.
    Hassanein M; Qian J; Hoeksema MD; Wang J; Jacobovitz M; Ji X; Harris FT; Harris BK; Boyd KL; Chen H; Eisenberg R; Massion PP
    Int J Cancer; 2015 Oct; 137(7):1587-97. PubMed ID: 25821004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.
    Hassanein M; Hoeksema MD; Shiota M; Qian J; Harris BK; Chen H; Clark JE; Alborn WE; Eisenberg R; Massion PP
    Clin Cancer Res; 2013 Feb; 19(3):560-70. PubMed ID: 23213057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation.
    Yu X; Plotnikova O; Bonin PD; Subashi TA; McLellan TJ; Dumlao D; Che Y; Dong YY; Carpenter EP; West GM; Qiu X; Culp JS; Han S
    Elife; 2019 Oct; 8():. PubMed ID: 31580259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.
    Zhou X; Zheng W; Nagana Gowda GA; Raftery D; Donkin SS; Bequette B; Teegarden D
    J Steroid Biochem Mol Biol; 2016 Oct; 163():147-56. PubMed ID: 27154413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
    van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
    Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab.
    Ma H; Wu Z; Peng J; Li Y; Huang H; Liao Y; Zhou M; Sun L; Huang N; Shi M; Bin J; Liao Y; Rao J; Wang L; Liao W
    Int J Cancer; 2018 Jun; 142(12):2578-2588. PubMed ID: 29363109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis.
    Wu B; Chen Y; Chen Y; Xie X; Liang H; Peng F; Che W
    Thorac Cancer; 2022 Jun; 13(12):1795-1805. PubMed ID: 35567340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
    Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
    Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
    J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma.
    Luo M; Wu L; Zhang K; Wang H; Zhang T; Gutierrez L; O'Connell D; Zhang P; Li Y; Gao T; Ren W; Yang Y
    Cell Death Differ; 2018 Aug; 25(8):1457-1472. PubMed ID: 29348676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
    Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
    J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.
    Yoo HC; Park SJ; Nam M; Kang J; Kim K; Yeo JH; Kim JK; Heo Y; Lee HS; Lee MY; Lee CW; Kang JS; Kim YH; Lee J; Choi J; Hwang GS; Bang S; Han JM
    Cell Metab; 2020 Feb; 31(2):267-283.e12. PubMed ID: 31866442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SLC1A5 blocks cell proliferation through inhibition of mTORC1 in arsenite-treated human uroepithelial cells.
    Li S; Zhou Q; Liu W; Fu Z; Zhao H; Xi S
    Toxicol Lett; 2021 Jul; 345():1-11. PubMed ID: 33781819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.